NCT02224781
Clinical Trial Information
Trial Number: NCT02224781 (ClinicalTrials.gov)
Disease Type:
- Skin Neoplasm - Melanoma
Trial Title:
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Study ID:
EA6134
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®